(Q45887188)
Statements
1 reference
Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). (English)
1 reference
H E Heslop
1 reference
G D Myers
1 reference
R A Krance
1 reference
H Weiss
1 reference
I Kuehnle
1 reference
G Demmler
1 reference
C M Bollard
1 reference
1 December 2005
1 reference
1 reference
36
1 reference
11
1 reference
1001-1008
1 reference
Identifiers
1 reference
1 reference